Efficacy of fractional CO 2 laser in the treatment of genitourinary syndrome of menopause in Latin-American Population: First Peruvian experience

This PUBA study aimed to assess the efficacy of fractional CO2 laser in the treatment of genitourinary syndrome of menopause (GSM). GSM symptoms were assessed before, 1 month after the first session and 1 month after the third session of laser (3 sessions with a 30 days interval between them) in 60...

Full description

Saved in:
Bibliographic Details
Published in:Lasers in surgery and medicine 2019-08, Vol.51 (6), p.509-515
Main Authors: Tovar-Huamani, Juan, Mercado-Olivares, Felipe, Grandez-Urbina, Jose Antonio, Pichardo-Rodriguez, Rafael, Tovar-Huamani, Marco, García-Perdomo, Herney
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This PUBA study aimed to assess the efficacy of fractional CO2 laser in the treatment of genitourinary syndrome of menopause (GSM). GSM symptoms were assessed before, 1 month after the first session and 1 month after the third session of laser (3 sessions with a 30 days interval between them) in 60 women (median, interquartile range: 55, 49-69). Subjective (visual analog scale) and objective (Vaginal Health Index, VHIS; Vaginal Maturity Index/Frost Index; Spanish Overactive Bladder Questionnaire-Short Form, USMEX Spanish OAB-qSF and Female Sexual Function Index, FSFI) measures were used during the study period to assess CO2 fractionated laser treatment outcomes compared to baseline. Fractional CO laser treatment was effective to improve GSM symptoms (vaginal dryness, vaginal itching, vaginal burning, dyspaurenia, dysuria, urinary urgency; P 
ISSN:0196-8092
1096-9101
DOI:10.1002/lsm.23066